|
Post by falconquest on Jan 8, 2019 6:03:45 GMT -5
Why are we under $50 a share right now is beyond me..funded company..FDA approved inhaled insulin..Receptor Life Cannabis partner..UTHR..deal..factory worth more than the market cap..patents worth 3 x that..then there is Technovax..and what happened with Torrey Pines..safe and affective Morphine cant overdose non attictive?...I just don't get it $1.20?..are analyst really this stupid? I guess they are..but..while it's this cheap..and they remain stupid..I might as well collect a few more shares..ha! Easy, none of this has translated into enough revenue YET. Bingo!
|
|
|
Post by travis1953 on Jan 8, 2019 6:09:47 GMT -5
Is "spiresta" a competitor for MNKD's version of trepostinil?
|
|
|
Post by sportsrancho on Jan 8, 2019 6:51:16 GMT -5
|
|
|
Post by sportsrancho on Jan 8, 2019 8:07:52 GMT -5
|
|
|
Post by pat on Jan 8, 2019 8:18:37 GMT -5
Yep
When im paying for stuff later in life i won't tell my grandkids "I invested in this stock" instead it'll be "I invested in this stock and waited, and waited and waited and waited...for 12 years I waited"
then ill I'll turn it into a teaching moment
and I'll tell the story all the time to the point they know it by heart.
|
|
|
Post by veritasfiliatemporis on Jan 8, 2019 8:32:48 GMT -5
|
|
|
Post by boca1girl on Jan 8, 2019 8:47:32 GMT -5
I funded a Roth IRA for each of my 6 nephews/niece just prior to Sanofi ending the partnership. I bought them 1500 shares each (now 300).
Since that time, I’ve been explaining reverse splits, importance of cash flow, bankruptcy, increasing authorized shares, dilution, warrants, and above all patience.
This has been a “baptizim by fire” learning experience in the world of stock investing for them. I still have high hopes that the experience will pay off for us.
|
|
|
Post by Clement on Jan 8, 2019 8:56:14 GMT -5
Rothblatt explained that Spiresta is for rescue (and is not the replacement for Tyvaso nebulizer).
Treprostinil Technospere is being developed to replace the Tyvaso Nebulizer. Tyvaso net sales in Q3 2018 was $108 million.
|
|
|
Post by markado on Jan 8, 2019 9:00:23 GMT -5
The YouTube video clip was great. No matter how many ways it may be linked or shared, and I hope much so, it relates the variety of ways MNKD is unlocking value in 2019.
2019...The year for MNKD!
|
|
|
Post by thekid2499 on Jan 8, 2019 9:42:28 GMT -5
Between listening to the conference call last week and the actions of MNKD, I think it is fairly obvious to me (at this point that Mike knows that Afrezza has a long, hard-fought slog to profitability. I don't expect hockey stick growth, but instead linear growth over time. Afrezza, despite MNKD's efforts, may be 3 years away from profitability. There are myriad reasons for that, some because of MNKD and some completely out of their control. I think we have seen MNKD try to pivot to Technosphere to try to unlock value in the next few years and, quite frankly, to help fund the company and Afrezza efforts. We are going to need that as longs because I don't see how Afrezza growth over the next few years will increase the share price. I hope I am wrong and we can all laugh at me at the end of 2019.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 8, 2019 9:46:51 GMT -5
|
|
|
Post by wsulylecoug on Jan 8, 2019 10:39:55 GMT -5
95% of me is pretty excited about the prospects of the cannabinoid space with RLS, the other 5% of me gets a familiar feeling of the epinephrine chatter when it was a hot topic. Not trying to be a debbie downer, but trying to keep hope and expectations a tad bit in check...RLS is still a bit nebulous to me. I like the multi-pronged attack for new TS compounds and if just one more turns into something similar to UTHR, wheeeee!
|
|
|
Post by #NoMoreNeedles on Jan 8, 2019 10:42:26 GMT -5
RLS is at least 3 years away from any FDA approvals.
|
|
|
Post by mango on Jan 8, 2019 10:58:15 GMT -5
RLS is at least 3 years away from any FDA approvals. Mike said RLS was also doing over the counter products too. I believe RLS has Canada as one of their target locations.
|
|
|
Post by kite on Jan 8, 2019 11:02:54 GMT -5
RLS is at least 3 years away from any FDA approvals. Well we better get the ball rolling now (hopefully the ball has continued to roll since this collaboration was first announced)...
|
|